File Download

Conference Paper: Role of miR-338-5p as a novel modulator of chemoresistannce in esophageal cancer

TitleRole of miR-338-5p as a novel modulator of chemoresistannce in esophageal cancer
Authors
Issue Date2015
PublisherThe European CanCer Organisation (ECCO)
Citation
The 2015 EACR-AACR-SIC Special Conference (EAS 2015), Florence, Italy, 20-23 June 2015. In Abstracts Book, 2015, p. 65-66, abstract no. 160 How to Cite?
AbstractINTRODUCTION: Multimodal treatment incorporating surgical resection and the use of chemotherapeutic drugs is commonly used in the management of esophageal cancer. However, resistance to chemotherapy drugs may contribute to poor treatment outcome and cancer recurrence. Increasing evidence suggests that miRNAs regulate the sensitivity of cancer to chemotherapeutic drugs. 5-Fluorouracil (5-FU) is an antimetabolite agent ...
DescriptionConference Theme: Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic
Persistent Identifierhttp://hdl.handle.net/10722/211103

 

DC FieldValueLanguage
dc.contributor.authorCheung, A-
dc.contributor.authorHan, L-
dc.contributor.authorTsao, SW-
dc.contributor.authorLaw, S-
dc.contributor.authorChan, KW-
dc.contributor.authorLi, B-
dc.date.accessioned2015-07-07T07:54:25Z-
dc.date.available2015-07-07T07:54:25Z-
dc.date.issued2015-
dc.identifier.citationThe 2015 EACR-AACR-SIC Special Conference (EAS 2015), Florence, Italy, 20-23 June 2015. In Abstracts Book, 2015, p. 65-66, abstract no. 160-
dc.identifier.urihttp://hdl.handle.net/10722/211103-
dc.descriptionConference Theme: Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic-
dc.description.abstractINTRODUCTION: Multimodal treatment incorporating surgical resection and the use of chemotherapeutic drugs is commonly used in the management of esophageal cancer. However, resistance to chemotherapy drugs may contribute to poor treatment outcome and cancer recurrence. Increasing evidence suggests that miRNAs regulate the sensitivity of cancer to chemotherapeutic drugs. 5-Fluorouracil (5-FU) is an antimetabolite agent ...-
dc.languageeng-
dc.publisherThe European CanCer Organisation (ECCO)-
dc.relation.ispartofEACR-AACR-SIC Special Conference, EAS 2015-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleRole of miR-338-5p as a novel modulator of chemoresistannce in esophageal cancer-
dc.typeConference_Paper-
dc.identifier.emailCheung, A: lmcheung@hku.hk-
dc.identifier.emailTsao, SW: gswtsao@hku.hk-
dc.identifier.emailLaw, S: slaw@hkucc.hku.hk-
dc.identifier.emailChan, KW: hrmtckw@hkucc.hku.hk-
dc.identifier.authorityCheung, A=rp00332-
dc.identifier.authorityTsao, SW=rp00399-
dc.identifier.authorityLaw, S=rp00437-
dc.identifier.authorityChan, KW=rp00330-
dc.description.naturepostprint-
dc.identifier.hkuros244724-
dc.identifier.spage65, abstract no. 160-
dc.identifier.epage66-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats